D-1385-2019 Class II Terminated

Recalled by Torrent Pharma Inc — Levittown, PA

FDA drug recall D-1385-2019 was initiated by Torrent Pharma Inc on May 21, 2019 and is designated Class II. Reason for recall: cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii). The recall status is terminated (terminated Oct 6, 2020).

Recall details

Product Type
Drugs
Report Date
Jun 19, 2019
Initiation Date
May 21, 2019
Termination Date
Oct 6, 2020
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Bisacodyl Suppositories, Brite Stock, Reese.

Reason for recall

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Distribution pattern

Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.

Code information

Lot #s: 17J003, Exp. 09/2019; 18A026, Exp. 01/2020; 18E031, Exp. 05/2020.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1385-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1385-2019. Report a data issue: hello@regdatalab.com.